Glenmark Pharmaceuticals Inc., USA Recall: Glenmark Ranitidine Tablets USP 300 mg Rx Only
Glenmark Pharmaceuticals Inc., USA Recall: Glenmark Ranitidine Tablets USP 300 mg Rx Only is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Glenmark Pharmaceuticals Inc., USA; Product: Glenmark Ranitidine Tablets USP 300 mg Rx Only 100 Tablets Manufactured by: Glenmark Pharmaceuticals Lt
| Recalling firm | Glenmark Pharmaceuticals Inc., USA |
|---|---|
| Product | Glenmark Ranitidine Tablets USP 300 mg Rx Only 100 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ NDC 68462-249-01 |
| Reason for recall | CGMP Deviations: Presence of NDMA impurity detected in product. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Ongoing |
| Distribution | Natiowide |
| Recall initiated | 20191217 |
| Recall number | D-0642-2020 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →